Vitamin D Council needs your help...

Tax-deductible!

Together we can end the illness and disease caused by the worldwide epidemic of vitamin D deficiency.

About Vitamin D Council

Contact Vitamin D Council

Sponsor Vitamin D Council

Follow us on:

Vitamin D Products

(off-site)

These companies donate to the Vitamin D Council.

D-Lite, Renew, & SunSplash UV/Tanning Systems
In-Home ZRT Vitamin D Blood Test Kit
Get Premium Quality Vitamin D Supplements at Great Prices
Vitamin D3 Plus™ from Bio-Tech — contains the cofactors Vitamin D needs to work properly.

Vitamin D Research

back to research menu

Diabetes

Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med Hypotheses. 2010 Jan;74(1):71–5.
Moderate alcohol intake is associated with decreased risk of insulin resistance among individuals with vitamin D insufficiency. Nutrition. 2010 Jan;26(1):100–5.
Possible Health Implications and Low Vitamin D Status during Childhood and Adolescence: An Updated Mini Review. Int J Endocrinol. 2010;2010:472173.
Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010:351385.
Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas. 2009 Dec 21.
The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. Eur J Epidemiol.
Can vitamin D intake assist in improving the outcome of endodontic treatment for diabetic patients? Med Hypotheses. 2009 Dec 2.
Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India. PLoS One. 2009 Dec 2;4(12):e8023.
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. Prog Lipid Res.
Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009 Dec;16(6):435–45.
Vitamin D and calcium insufficiency-related chronic diseases- molecular and cellular pathophysiology. Eur J Clin Nutr. 2009 Dec;63(12):1377–86.
Epidemiology of vitamin D in health and disease. Nutr Res Rev. 2009 Dec;22(2):188–203.
The effect of 1alpha,25(OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where Type 1 diabetes is formed by streptozotocin. J Diabetes Complications. 2009 Nov–Dec;23(6):401–8.
Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes. 2009 Nov 9.
The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009 Nov;45(5):949–55.
Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin Immunol. 2009 Nov;133(2):276–81.
Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care. 2009 Nov;32(11):1977–9.
Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 1 diabetes. Int J Infect Dis. 2009 Nov;13(6):e437–43.
Guidelines for vitamin D prescription in dialysis patients. Nephrol Ther. 2009 Nov;5(6):520–32.
The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract. 2009 Oct 27.
Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia. 2009 Oct 13.
The big D. Looking for links between type 2 diabetes and vitamin D. Diabetes Forecast. 2009 Oct;62(10):67–8.
Does vitamin D status contribute to caveolin-1-mediated insulin sensitivity in skeletal muscle? Diabetologia. 2009 Oct;52(10):2240; author reply 2241–3.
Incidence of insulin-requiring diabetes in the US military. Diabetologia. 2009 Oct;52(10):2087–91.
25-hydroxyvitamin D and cardiovascular risk factors in women with systemic lupus erythematosus. Arthritis Rheum. 2009 Sep 29;61(10):1387–1395.
Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2009 Sep 28:1–7.
A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy. Nephrol Dial Transplant. 2009 Sep 27.
Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009 Sep 24.
High prevalence of vitamin D deficiency in type 1 diabetes mellitus and healthy children. Acta Diabetol. 2009 Sep;46(3):183–9.
Serum Osteocalcin/Bone-Specific Alkaline Phosphatase Ratio Is a Predictor for the Presence of Vertebral Fractures in Men with Type 2 Diabetes. Calcif Tissue Int. 2009 Jul 30.
Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing. 2009 Jul 18.
Vitamin D in diabetes mellitus—a new field of knowledge poised for D-velopment. Diabetes Metab Res Rev. 2009 Jul;25(5):417–9.
Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev. 2009 Jul;25(5):411–6.
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009 Jun 20.
The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics. Am J Nephrol. 2009 Jun 15;30(3):280–286.
Circulating calcitriol concentrations and total mortality. Clin Chem. 2009 Jun;55(6):1163–70.
Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009 Jun;39(6):875–82.
Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev. 2009 Jun 1;25(5):411–416.
Prevalence of vitamin D receptor gene polymorphisms FokI and BsmI in Brazilian individuals with type 1 diabetes and their relation to beta-cell autoimmunity and to remaining beta-cell function. Hum Immunol. 2009 Jun;70(6):447–51.
Poor vitamin D status may contribute to high risk for insulin resistance, obesity, and cardiovascular disease in Asian Indians. Med Hypotheses. 2009 Jun;72(6):647–51.
Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009 Jun;22(1):82–92.
Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time. Pediatr Diabetes. 2009 Jun;10(4):248–54.
Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur J Clin Nutr. 2009 May;63(5):646–52.
Vitamin d. Int J Biochem Cell Biol. 2009 May;41(5):982–5.
Can moderate elevations of parathyroid hormone acutely increase risk for ischemic cardiac arrhythmias? Med Hypotheses. 2009 May;72(5):581–3.
Vitamin D and type 2 diabetes Is there a link? Prim Care Diabetes. 2009 Apr 21.
Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr. 2009 Apr 16.
Circulating Calcitriol Concentrations and Total Mortality. Clin Chem. 2009 Apr 9.
Origin of the mediacalcosis in kidney failure. J Mal Vasc. 2009 Apr 2.
Serum 25-hydroxyvitamin D and IgE - a significant but nonlinear relationship. Allergy. 2009 Apr;64(4):613–620.
Regulation by 1, 25-dihydroxy-vitamin D3 on altered TLRs expression and response to ligands of monocyte from autoimmune diabetes. Clin Chim Acta. 2009 Apr;402(1–2):133–8.
Hip fractures in the elderly in Israel—possible impact of preventable conditions. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):182–5.
Hip fractures in the elderly in Israel—possible impact of preventable conditions. Arch Gerontol Geriatr. 2009 Mar–Apr;48(2):182–5.
Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol. 2009 Mar 3.
25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant. 2009 Feb;24(2):611–8.
A comparison of vitamin d levels in nondiabetic and diabetic patient populations. J Am Podiatr Med Assoc. 2009 Jan–Feb;99(1):35–41.
Significant Vitamin D Deficiency in Youth with Type 1 Diabetes Mellitus. Journal of Pediatrics. 2009 Jan;154(1):132–134.
Low serum 25 (OH) vitamin D levels ( Transl Res. 2009 Jan;153(1):11–6.
Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009 Jan;94(1):26–34.
Plasma 25-Hydroxyvitamin D Is Associated with Markers of the Insulin Resistant Phenotype in Nondiabetic Adults. J Nutr. 2008 Dec 23.
Vitamin D: current status and perspectives. Clin Chem Lab Med. 2008 Dec 22.
Type 1 diabetes, the A1 milk hypothesis and vitamin D deficiency. Diabetes Res Clin Pract. 2008 Dec 17.
Vitamin d deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008 Dec 9;52(24):1949–56.
Vitamin D deficiency is the cause of common obesity. Med Hypotheses. 2008 Dec 1.
Does vitamin D make the world go 'round'? Mol Aspects Med. 2008 Dec;29(6):369–75. Review.
Geographic location and vitamin D synthesis. Mol Aspects Med. 2008 Dec;29(6):453–61.
The vitamin D deficiency pandemic and consequences for nonskeletal health: Mechanisms of action. Mol Aspects Med. 2008 Dec;29(6):361–8. Review.
Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities. Mol Aspects Med. 2008 Dec;29(6):376–87.
Vitamin D and diabetes: let the sunshine in. Diabetes Educ. 2008 Nov–Dec;34(6):939–40, 942, 944 passim.
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008 Oct;29(6):726–76. Review.
Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male. 2008 Sep;11(3):134–9.
The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecol Endocrinol. 2008 Sep;24(9):514–8.
Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology. 2008 Sep;19(5):666–71.
Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008 Sep;3(5):1535–41.
Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am J Epidemiol. 2008 Aug 15;168(4):358–65.
25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 Aug 11;168(15):1629–37.
Gestational diabetes mellitus and vitamin D deficiency: genetic contribution of CYP27B1 and CYP2R1 polymorphisms. Diabetes Obes Metab. 2008 Aug;10(8):683–5.
Vitamin D and anti-aging medicine. Clin Calcium. 2008 Jul;18(7):980–5. Review in Japanese.
Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008 Jul;3(4):1144–51.
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008 Jun 4;100(11):796–804.
Vitamin D and living in northern latitudes—an endemic risk area for vitamin D deficiency. Int J Circumpolar Health. 2008 Jun;67(2–3):164–78. Review.
Osteoporosis among patients with type 1 and type 2 diabetes. Diabetes Metab. 2008 Jun;34(3):193–205. Review.
Insulin resistance, renal injury, renal 1-alpha hydroxylase, and bone homeostasis in aged obese rats. Arch Med Res. 2008 May;39(4):380–7.
Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res. 2008 Mar;127(3):229–38. Review.
Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008 Feb;57(2):183–91.
Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population. Hum Immunol. 2008 Feb;69(2):134–8.
Correlation between vitamin D(3) deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev. 2008 Jan–Feb;24(1):27–32.
Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol Dial Transplant. 2008 Jan;23(1):269–74.
Vitamin D: molecular mechanism of action. Ann N Y Acad Sci. 2007 Nov;1116:340–8. Review.
CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab Res Rev. 2007 Nov;23(8):631–6.
Vitamin D insufficiency—possible etiologic factor of autoimmune diseases. Ugeskr Laeger. 2007 Oct 22;169(43):3655–60. Review in Danish.
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007 Sep 10;167(16):1730–7. Review.
What is new in vitamin D: 2006–2007. Curr Opin Rheumatol. 2007 Jul;19(4):383–8.
Seasonality of month of birth of patients with Graves' and Hashimoto's diseases differ from that in the general population. Eur J Endocrinol. 2007 Jun;156(6):631–6.
The Role of Vitamin D and Calcium in type 2 diabetes. A systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2007 Jun;92(6):2017–29. Review.
The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Non-diabetic Adults. Diabetes Care. 2007 Apr;30(4):980–6.
Vitamin D and outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens. 2007 Mar;16(2):77–82.
Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency. Am J Med Sci. 2007 Jan;333(1):58–62.
25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007 Jan;71(2):134–9.
Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes. 2007;56:2616–2621.
Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia. 2006 Dec;49(12):2847–52.
Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf). 2006 Nov;65(5):593–597.
Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006 Oct;66(4):247–55.
Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. Pediatr Nephrol. 2006 Oct;21(10):1434–9.
Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol. 2006 Sep;92(1):65–79. Review.
Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients. Nephrol Dial Transplant. 2006 Sep;21(9):2621–4.
Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006 Sep;92(1):39–48. Review.
Vitamin D physiology. Prog Biophys Mol Biol. 2006 Sep;92(1):4–8. Review.
Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):640–6.
Vitamin D metabolism in peripheral blood mononuclear cells is influenced by chewing "betel nut" (Areca catechu) and vitamin D status. J Clin Endocrinol Metab. 2006 Jul;91(7):2612–7.
A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care. 2006 Jul;29(7):1579–84.
Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005 Dec;28(12):2926–32.
Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med J. 2005 Oct;98(10):1024–7. Review.
Vitamin D endocrine system and the genetic susceptibility to diabetes, obesity and vascular disease. A review of evidence. Diabetes Metab. 2005 Sep;31(4 Pt 1):318–25. Review.
Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus. Autoimmunity. 2005 Sep;38(6):439–44.
Vitamin D for health and in chronic kidney disease. Semin Dial. 2005 Jul–Aug;18(4):266–75. Review.
The role of vitamin D in protecting type 1 diabetes mellitus. Diabetes Metab Res Rev. 2005 Jul–Aug;21(4):338–46. Review.
Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev. 2005 Jun;10(2):94–111. Review.
Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest. 2005 May;35(5):290–304. Review.
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatr Nephrol. 2005 May;20(5):622–30.
Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Prev. 2005 Apr–Jun;6(2):147–52.
Vitamin D and the elderly. Clin Endocrinol (Oxf). 2005 Mar;62(3):265–81. Review.
Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients? J Nephrol. 2005 Jan–Feb;18(1):96–101.
Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study. Ren Fail. 2005;27(2):205–12.
Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004 Sep 1;338(2):143–56. Review.
Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004 May;79(5):820–5.
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar;79(3):362–71. Review.
Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus. Arch Biochem Biophys. 2003 Sep 1;417(1):77–80.
The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003 May;57(4):258–61.
Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci. 2003 Apr;987:258–61. Review.
The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277–300. Review.
Vitamin D and autoimmune diabetes. J Cell Biochem. 2003 Feb 1;88(2):216–22. Review.
Ultraviolet radiation and health: friend and foe. Med J Aust. 2002 Dec 2–16;177(11–12):594–8.
The role of vitamin D in mild to moderate chronic kidney disease. Trends Endocrinol Metab. 2002 Jul;13(5):189–94. Review.
New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002 Apr;13(3):100–5. Review.
Can vitamin D supplementation in infancy prevent type 1 diabetes? Nutr Rev. 2002 Apr;60(4):118–21. Review.
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001 Nov 3;358(9292):1500–3.
Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall study. Int J Epidemiol. 2001 Oct;30(5):1109–16.
Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia. Nephrol Dial Transplant. 2001 May;16(5):1009–16.
Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol. 2001 Apr;144(4):385–9.
Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia. 2000 Sep;43(9):1093–8.
1,25-Dihydroxyvitamin D3—a hormone with immunomodulatory properties. Z Rheumatol. 2000;59 Suppl 1:24–7. Review.
Effect of calcitriol and age on recovery from hypocalcemia in hemodialysis patients. Am J Kidney Dis. 1999 Sep;34(3):456–63.
Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient. Kidney Int. 1999 Jul;56(1):306–17.
Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The Eurodiab Substudy 2 Study Group. Diabetologia. 1999 Jan;42(1):51–4.
Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S48–54.
19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol. 1998 Aug;9(8):1427–32.
A crossover comparison of intermittent oral and intravenous administration of calcitriol on the parathyroid hormone concentration in hemodialysis patients. Miner Electrolyte Metab. 1997;23(1):13–8.
"Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study. Nephron. 1997;77(3):267–72.
Pharmacokinetics and efficacy of pulse oral versus intravenous calcitriol in hemodialysis patients. J Am Soc Nephrol. 1996 Mar;7(3):488–96.
Different effects of calcitriol and parathyroidectomy on the PTH-calcium curve in dialysis patients with severe hyperparathyroidism. Nephrol Dial Transplant. 1996 Jan;11(1):81–7.
Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract. 1995 Mar;27(3):181–8.
Suppression of secondary hyperparathyroidism in chronic dialysis patients by single oral weekly dose of 1,25-dihydroxycholecalciferol. Intern Med. 1993 Sep;32(9):695–701.
Secondary hyperparathyroidism in elderly people: combined effect of renal insufficiency and vitamin D deficiency. Am J Clin Nutr. 1993 Aug;58(2):187–91.
Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron. 1992;61(4):422–7.
Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism. Nephrol Dial Transplant. 1992;7(8):822–8.
The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol. 1991 Nov;2(5):1014–20.
The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism. Nephron. 1991;57(1):23–8.
Bone mineral content, 25-hydroxycalciferol and zinc serum levels in insulin-dependent (type I) diabetic patients. Arch Invest Med (Mex). 1990 Apr–Jun;21(2):195–9.
Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int. 1989 Dec;36(6):1093–8.
Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab. 1988 Nov;67(5):876–81.
Alterations in vitamin D metabolites and minerals in diabetic pregnancy. Gynecol Obstet Invest. 1988;25(2):99–105.
Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia. 1986 Mar;29(3):142–5.
Serum phosphate, parathyroid hormone and vitamin D metabolites in patients with chronic renal failure: effect of aluminum hydroxide administration. Nephron. 1985;40(3):286–91.
Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest. 1984 Dec;74(6):2136–43.
Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab. 1984 Dec;59(6):1063–9.
Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J Clin Invest. 1984 Jun;73(6):1580–9.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.